Eva M. Carmona

Prof. Eva M. Carmona

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA Department of Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota, USA.

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Clinics in Chest Medicine
Verified
Journal Article
Closed access
ECEva M. Carmona
Eva M. Carmona
ALAndrew H. Limper
Andrew H. Limper

1 December 2015 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MAMohamed F. Ali
Mohamed F. Ali
CDChristopher B. Driscoll
Christopher B. Driscoll
PWPaula R. Walters
Paula R. Walters
ALAndrew H. Limper
Andrew H. Limper
ECEva M. Carmona
Eva M. Carmona
B lymphocytes play an essential regulatory role in the adaptive immune response through Ab production during infection. A less known function of B lymphocytes is their ability to respond directly to infectious Ags through stimulation of pattern recognition receptors expressed on their surfaces. β-Glucans are carbohydrates present in the cell wall of many pathogenic fungi that can be detected in the peripheral blood of patients during infection. They have been shown to participate in the innate inflammatory response, as they can directly activate peripheral macrophages and dendritic cells. However, their effect as direct stimulators of B lymphocytes has not been yet fully elucidated. The aim of this study was to examine the molecular mechanisms and cytokine profiles generated following β-glucan stimulation of B lymphocytes, compared with the well-established TLR-9 agonist CpG oligodeoxynucleotide (CpG), and study the participation of β-glucan–stimulated B cells in the innate immune response. In this article, we demonstrate that β-glucan–activated B lymphocytes upregulate proinflammatory cytokines (TNF-α, IL-6, and IL-8). Of interest, β-glucan, unlike CpG, had no effect on B lymphocyte proliferation or IgM production. When compared with CpG (TLR9 agonist), β-glucan–activated cells secreted significantly higher levels of IL-8. Furthermore, IL-8 secretion was partially mediated by Dectin-1 and required SYK, MAPKs, and the transcription factors NF-κB and AP-1. Moreover, we observed that conditioned media from β-glucan–stimulated B lymphocytes elicited neutrophil chemotaxis. These studies suggest that β-glucan–activated B lymphocytes have an important and novel role in fungal innate immune responses.

9 November 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
MAMohamed F. Ali
Mohamed F. Ali
HDHarika Dasari
Harika Dasari
VKVirginia P. Van Keulen
Virginia P. Van Keulen
ECEva M. Carmona
Eva M. Carmona
The NLRP3 inflammasome is activated in response to different bacterial, viral and fungal pathogens and serves as modulator of different pattern recognition receptors signaling pathways. One of the main functions of NLRP3 is to participate in IL-1beta maturation which is important in the host defense against Pneumocystis and other fungal infections. However, dysregulation of NLRP3 and IL-1beta secretion are also implicated in the pathophysiology of many auto-inflammatory disorders. Often time’s inflammatory flares are preceded by infectious illnesses questioning the role of infection in autoimmune exacerbations. However, we still do not fully understand the exact role that infection or even colonization plays as triggers of inflammation. Herein, we investigated the role of NLRP3 in circulating B-lymphocytes following activation with two major microbial antigens (beta-glucan and CpG) NLRP3 was determined essential in two independent B-lymphocytes processes: pro-inflammatory cytokine secretion and antibody regulation. Our results show that the β-glucan fungal cell wall carbohydrate, stimulated B-lymphocytes to secreted IL-1β in a process partially mediated by Dectin-1 activation via SYK and the transcription factors NF-kappaB and AP-1. This IL-1beta secretion was regulated by the NLRP3 inflammasome and was dependent on potassium efflux and Caspase-1. Interestingly, B-lymphocytes activated by unmethylated CpG motifs, found in bacterial and fungal DNA, failed to induce IL-1beta. However, B-lymphocyte stimulation by CpG resulted in NLRP3 and Caspase-1 activation and the production and secretion of IgM antibodies. Furthermore, CpG-stimulated IgM secretion, unlike beta-glucan-mediated IL-1beta production, was mediated by the mammalian target of rapamycin (mTOR). Inhibition of NLRP3 and the mTOR pathway in CpG activated B-lymphocytes resulted in impaired IgM secretion suggesting their participation in antibody regulation. In conclusion, this study describes a differential response of NLRP3 to beta-glucan and CpG antigens and identifies the NLRP3 inflammasome of human circulating B-lymphocytes as a modulator of the innate and adaptive immune systems.

1 June 2021 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
MAMohamed F. Ali
Mohamed F. Ali
AEAshley M. Egan
Ashley M. Egan
GSGaja F. Shaughnessy
Gaja F. Shaughnessy
DADagny K. Anderson
Dagny K. Anderson
TKTheodore J. Kottom
Theodore J. Kottom
ECEva M. Carmona
Eva M. Carmona
B-cell activation is increasingly linked to numerous fibrotic lung diseases, and it is well known that aggregates of lymphocytes form in the lung of many of these patients. Activation of B-cells by pattern recognition receptors (PRRs) drives the release of inflammatory cytokines, chemokines, and metalloproteases important in the pathophysiology of pulmonary fibrosis. However, the specific mechanisms of B-cell activation in patients with idiopathic pulmonary fibrosis (IPF) are poorly understood. Herein, we have demonstrated that B-cell activation by microbial antigens contributes to the inflammatory and profibrotic milieu seen in patients with IPF. B-cell stimulation by CpG and β-glucan via PRRs resulted in activation of mTOR-dependent and independent pathways. Moreover, we showed that the B-cell–secreted inflammatory milieu is specific to the inducing antigen and causes differential fibroblast migration and activation. B-cell responses to infectious agents and subsequent B-cell–mediated fibroblast activation are modifiable by antifibrotics, but each seems to exert a specific and different effect. These results suggest that, upon PRR activation by microbial antigens, B-cells can contribute to the inflammatory and fibrotic changes seen in patients with IPF, and antifibrotics are able to at least partially reverse these responses.

1 July 2016 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
ECEva M. Carmona
Eva M. Carmona
SKSanjay Kalra
Sanjay Kalra
JRJay Ryu
Jay Ryu

13 July 2010 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ECEva M. Carmona
Eva M. Carmona
JLJeffrey D Lamont
Jeffrey D Lamont
AXAiling Xue
Ailing Xue
MWMark Wylam
Mark Wylam
ALAndrew Limper
Andrew Limper
Respiratory failure secondary to alveolar inflammation during Pneumocystis pneumonia is a major cause of death in immunocompromised patients. Neutrophil infiltration in the lung of patients with Pneumocystis infection predicts severity of the infection and death. Several previous studies indicate that airway epithelial cells release the neutrophil chemoattractant proteins, MIP-2 (rodents) and IL-8 (humans), in response to Pneumocystis and purified Pneumocystis cell wall β-glucans (PCBG) through the NF-κB-dependent pathway. However, little is known about the molecular mechanisms that are involved in the activation of airway epithelium cells by PCBG resulting in the secretion of IL-8.